Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

News Conference News AHA 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

November 13, 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

November 05, 2018

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

Presentation TCT 2018

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Thomas Engstrøm

September 24, 2018

“Transient” STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

March 12, 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

News Conference News ACC 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

March 11, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.